会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • 5-(3-Phenyl-3-oxo-propyl)-1H-tetrazole derivatives
    • 5-(3-苯基-3-氧代 - 丙基)-1H-四唑衍生物
    • US6133302A
    • 2000-10-17
    • US446895
    • 1999-12-30
    • Paolo PevarelloAntonio GiordaniManuela VillaCarmela SpecialeMario Varasi
    • Paolo PevarelloAntonio GiordaniManuela VillaCarmela SpecialeMario Varasi
    • A61K31/41A61P25/00A61P43/00C07D257/04
    • C07D257/04
    • 5-(3-phenyl-3-oxo-propyl)-1H-tetrazole derivatives of formula (I) wherein each of R and R.sub.1, being the same or different, is hydrogen, halogen, hydroxy, trifluoromethyl, cyano, nitro, phenyl, benzyl, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkylthio, SOR.sub.4 or SO.sub.2 R.sub.4 wherein R.sub.4 is C.sub.1 -C.sub.6 alkyl, --N(R.sub.5 R.sub.6) in which each of R.sub.5 and R.sub.6 is, independently, hydrogen, C.sub.1 -C.sub.6 alkyl, formyl or C.sub.2 -C.sub.6 acyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, benzyl, phenyl; R.sub.3 is hydrogen, hydroxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, benzyl, phenyl or a group --N(R.sub.7 R.sub.8) in which each of R.sub.7 and R.sub.8 is, independently, hydrogen, C.sub.1 -C.sub.4 alkyl, benzyl, phenyl, or one of R.sub.7 and R.sub.8 is hydrogen and the other is COR.sub.9 wherein R.sub.9 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, phenyl or a group --N(R.sub.10 R.sub.11) in which R.sub.10 and R.sub.11 are, each independently, hydrogen or C.sub.1 -C.sub.4 alkyl or, taken together, R.sub.2 and R.sub.3 form a carbocyclic C.sub.3 -C.sub.6 ring; and pharmaceutically acceptable salts thereof have kynurenine-3-hydroxylase enzyme inhibitory activity. ##STR1##
    • PCT No.PCT / EP98 / 04032 Sec。 371 1999年12月30日第 102(e)1999年12月30日PCT PCT。1998年6月25日PCT公布。 公开号WO99 /​​ 02506 日本1月21日,19995-(3-苯基-3-氧代 - 丙基)-1H-四唑衍生物,其中R和R 1相同或不同,为氢,卤素,羟基,三氟甲基, 氰基,硝基,苯基,苄基,C1-C6烷基,C1-C6烷氧基,C1-C6烷硫基,SOR4或SO2R4,其中R4是C1-C6烷基,-N(R5R6),其中R5和R6各自独立地为 氢,C 1 -C 6烷基,甲酰基或C 2 -C 6酰基; R2是氢,C1-C6烷基,C1-C6烷氧基,苄基,苯基; R3是氢,羟基,C1-C6烷基,C1-C6烷氧基,苄基,苯基或基团-N(R7R8),其中R7和R8各自独立地是氢,C1-C4烷基,苄基,苯基或 R 7和R 8中的一个是氢,另一个是COR 9,其中R 9是氢,C 1 -C 4烷基,C 1 -C 4烷氧基,苯基或基团-N(R 10 R 11),其中R 10和R 11各自独立地是氢或C1- C4烷基或一起为R2和R3形成碳环C 3 -C 6环; 及其药学上可接受的盐具有犬尿氨酸-3-羟化酶抑制活性。
    • 7. 再颁专利
    • Alpha-aminoamide derivatives useful as analgesic agents
    • 用作止痛剂的α-氨基酰胺衍生物
    • USRE40259E1
    • 2008-04-22
    • US11359982
    • 1998-12-12
    • Paolo PevarelloMario VarasiPatricia SalvatiClaes Post
    • Paolo PevarelloMario VarasiPatricia SalvatiClaes Post
    • A61K31/275A61K31/165C07C255/50C07C233/05
    • C07C237/06A61K31/165C07C255/54
    • The present invention relates to novel and known alpha-aminoamide compounds, to a process for their preparation, to pharmaceutical composition containing them and to their use as therapeutic agents.In particular, the compounds of the present invention are endowed with analgesic properties and are particularly useful for the treatment and alleviation of chronic and neuropathic pain.Accordingly, one object of the present invention is to provide the use of a compound of formula (I) wherein: A is a —(CH2)m—, —(CH2)n—X— or —(CH2)v—O— group wherein m is an integer of 1 to 4, n is zero or an integer of 1 to 4, X is —S— or —NH—, and v is zero or an integer of 1 to 5; s is 1 or 2; R is a furyl, thienyl, or pyridyl ring or a phenyl ring optionally substituted by one or two substituents independently chosen from halogen, cyano, C1-C4 alkyl, C1-C4 alkoxy and trifluoromethyl; R1 is hydrogen or C1-C4 alkyl; one of R2 and R3 is hydrogen and the other is hydrogen or C1-C4 alkyl optionally substituted by hydroxy or phenyl; or R2 and R3 taken together with the carbon atom to which they are linked form a C3-C6 cycloalkyl ring; or R2 and R3 are both methyl; R4 is hydrogen or C1-C4 alkyl.
    • 本发明涉及新的和已知的α-氨基酰胺化合物,其制备方法,含有它们的药物组合物及其作为治疗剂的用途。 特别地,本发明的化合物具有止痛特性,特别可用于治疗和缓解慢性和神经性疼痛。 因此,本发明的一个目的是提供式(I)化合物的用途,其中:A是 - (CH 2)n - , - ( CH 2 - (CH 2)n -X - 或 - (CH 2)2 -O - ,其中m是 1〜4的整数,n为0或1〜4的整数,X为-S-或-NH-,v为0或1〜5的整数。 s为1或2; R是呋喃基,噻吩基或吡啶基环或任选被一个或两个独立地选自卤素,氰基,C 1 -C 4烷基的取代基取代的苯环,C C 1 -C 4烷氧基和三氟甲基; R 1是氢或C 1 -C 4烷基; R 2和R 3中的一个是氢,另一个是氢或任选地是C 1 -C 4 - 被羟基或苯基取代; 或R 2和R 3与它们所连接的碳原子一起形成C 3 -C 6 - 环烷基环; 或R 2和R 3均为甲基; R 4是氢或C 1 -C 4烷基。
    • 8. 发明授权
    • Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
    • 噻吩化合物,其制备方法和含有它们的药物组合物
    • US06414013B1
    • 2002-07-02
    • US09596550
    • 2000-06-19
    • Daniele FancelliPaolo PevarelloMario Varasi
    • Daniele FancelliPaolo PevarelloMario Varasi
    • A61K3138
    • C07D409/12C07D333/38C07D333/68C07D413/12C07D473/00C07D495/04
    • Compounds which are 3-aminocarbonyl-2-carboxamido-thiophene derivatives of formula (I): wherein R1 and R2 are, independently from each other, hydrogen, halogen or an optionally substituted group selected from aryl, straight or branched C1-C6 alkyl or aryl C1-C6 alkyl; or, taken together with the thiophene bond to which they are linked, R1 and R2 form a —(CH2)m—(NR4)n—(CH2)p— group wherein m and p are, each independently, an integer form 1 to 3, n is 0 or 1 and m+n+p is an integer from 3 to 5; and R4 is hydrogen or an optionally substituted straight or branched C1-C6 alkyl group; R3 is a group, optionally further substituted, selected from: i) straight or branched C1-C8 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C2-C6 alkylcarbonyl; ii) aryl; iii) 3 to 7 membered carbocycle; iv) 5 to 7 membered heterocycle with from 1 to 3 heteroatoms selected from nitrogen, oxygen and sulphur; or a pharmaceutically acceptable salt thereof; are useful in the treatment of diseases associated with an altered protein kinase activity such as cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
    • 作为式(I)的3-氨基羰基-2-甲酰氨基 - 噻吩衍生物的化合物:其中R 1和R 2彼此独立地为氢,卤素或任选取代的基团,其选自芳基,直链或支链C 1 -C 6烷基或 芳基C1-C6烷基; 或者与它们所连接的噻吩键一起,R 1和R 2形成 - (CH 2)m - (NR 4)n - (CH 2)p - 基团,其中m和p各自独立地是1〜 3,n为0或1,m + n + p为3〜5的整数, 且R 4为氢或任选取代的直链或支链C 1 -C 6烷基; R 3是任选进一步取代的,选自:i)直链或支链C 1 -C 8烷基,C 2 -C 6烯基,C 2 -C 6炔基或C 2 -C 6烷基羰基; ii)芳基; iii)3至7元碳环; iv)具有1至3个选自氮,氧和硫的杂原子的5至7元杂环; 或其药学上可接受的盐; 可用于治疗与改变的蛋白激酶活性如癌症,阿尔茨海默病,病毒感染,自身免疫疾病和神经变性疾病相关的疾病。